Houston, TX12 Active Studies

Interstitial Lung Disease Clinical Trials in Houston, TX

Find 12 actively recruiting interstitial lung disease clinical trials in Houston, TX. Connect with local research sites and explore new treatment options.

12
Active Trials
11
Sponsors
16,708
Enrolling

Recruiting Interstitial Lung Disease Studies in Houston

About Interstitial Lung Disease Clinical Trials in Houston

Interstitial lung disease is a group of disorders characterized by progressive scarring of lung tissue, leading to breathlessness and reduced oxygen exchange. Causes include autoimmune diseases, environmental exposures, and unknown factors. Treatment includes antifibrotic medications and immunosuppressants.

There are currently 12 interstitial lung disease clinical trials recruiting participants in Houston, TX. These studies are seeking a combined 16,708 participants. Research is being sponsored by Boston Children's Hospital, University of California, Davis, Johns Hopkins University and 8 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Interstitial Lung Disease Clinical Trials in Houston — FAQ

Are there interstitial lung disease clinical trials in Houston?

Yes, there are 12 interstitial lung disease clinical trials currently recruiting in Houston, TX. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Houston?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Houston research site will contact you about next steps.

Are clinical trials in Houston free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Houston studies also compensate for your time and travel.

What interstitial lung disease treatments are being tested?

The 12 active trials in Houston are testing new therapies including novel drugs, biologics, and treatment approaches for interstitial lung disease.

Data updated August 30, 2026 from ClinicalTrials.gov